CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
CRISPR Therapeutics (NASDAQ: CRSP ) is one of the best stocks for 20 years . On February 12, CRISPR Therapeutics announced its financial results for 2025, highlighting a period of significant commercial and clinical growth. The company's flagship gene-editing therapy, CASGEVY, generated $116 million in total revenue for the year, with $54 million occurring in Q4 alone. This growth was driven by a nearly threefold increase in patient initiations compared to the previous year. To date, 147 patients have started the treatment process for sickle cell disease or beta thalassemia, supported by expanded reimbursement access across the US, Europe, and the Middle East. Beyond its commercial success, the company is advancing a diverse ‘in vivo' liver editing portfolio that delivers treatments directly to the body using lipid nanoparticles/LNP. Key programs include CTX310 for cardiovascular conditions and the upcoming CTX460 for alpha-1 antitrypsin deficiency, which is expected to enter clini
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes OfferingGlobeNewswire
- CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]Yahoo! Finance
- This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/11/26 - Form 8-K
- CRSP's page on the SEC website